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EDITORIAL
Childhood ADPKD: Answers and more questions
Over the past 15 years, it has become clear that autoso- kidneys. However, it is important to note that mean
mal-dominant polycystic kidney disease (ADPKD) (pre- glomerular filtration rates (GFRs; calculated by the
viously known as “adult polycystic kidney disease”) is Schwartz formula) were similar in affected versus unaf-
an important clinical entity in the pediatric population. fected children in all age groups and did not correlate
Indeed, 60% of children younger than 5 years of age, with mean renal volume. Unfortunately, only 108 of the
and 75 to 80% of children 5 to 18 years of age with a 182 ultrasound-positive children and 67 of the 127 unaf-
PKD-1 mutation have renal cysts detectable by ultra- fected children reported for more than one visit. There-
sound [1]. Renal cysts in children with ADPKD have fore, the presented curves of “mean renal volume” are
been associated with a wide clinical spectra, ranging from mathematical derivations of population data and cannot
totally asymptomatic patients to those who present as be used by clinicians to plot their own patients’ progres-
newborns with massive renal enlargement, hypertension, sive changes in renal volume. Despite these limitations,
oliguria, and pulmonary hypoplasia [2]. These latter pa- this study emphasizes an important message for clinicians
tients may be clinically indistinguishable from those with treating children with ADPKD. Hypertension should be
autosomal-recessive PKD. identified and aggressively treated, particularly in children
The clinical spectrum of childhood ADPKD has largely under 12 years of age with more than ten renal cysts.
been defined through study of the enormous clinical da- This is consistent with data emerging from clinical studies
tabase of ADPKD patients at the University of Colorado of the adult ADPKD population [7].
Health Sciences Center [3–5]. This clinical database, es- Like most valuable clinical studies, this current study
tablished over 30 years ago by the late Joseph Holmes, by Fick-Brosnahan et al generates more questions than
M.D., now consists of 420 ADPKD families from which it answers. Are changes in cyst size, cyst number, and
745 affected adults and 185 affected children have been renal size more accurately determined by radiocontrast-
studied by the Denver Polycystic Kidney Disease Re- enhanced computed tomography (CT) [8] or fast elec-
search Group. In this issue of Kidney International, Fick- tron-beam CT scanning [9]? Since progression of renal
Brosnahan et al have taken a critical step in bridging the disease in patients with ADPKD has been associated
descriptive phenomenology of the past to investigational with progressive interstitial fibrosis (which would be ex-
strategies of the future by providing detailed longitudinal pected to limit renal growth), is renal growth less likely to
data on the rate of progression of ADPKD in childhood correlate with disease progression at later disease stages?
and delineating factors associated with disease progres- What is the correlation of renal growth with nonrenal
sion [6]. Such data are critical to identify possible clinical manifestations of pediatric ADPKD such as cardiovascu-
outcome measures for interventional studies as well as lar abnormalities? Are there other clinical or laboratory
high-risk groups for targeted therapeutic intervention. parameters that can be used to monitor disease progres-
In their study, longitudinal mean renal volume curves sion or response to therapy? Now that disease-specific
were constructed from ultrasonographic renal measure- therapies are on the horizon for children (and adults)
ments of 182 affected and 127 unaffected children. Re- with ADPKD [7], the answers to these and other ques-
sults demonstrated that children with ADPKD had faster tions will be critical in the design of future interventional
renal growth than unaffected children, and that severe studies.
renal enlargement at a young age and/or hypertension
were risk factors for accelerated renal growth [6]. As Ellis D. Avner
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